Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $74.1800 (5.16%) ($69.7900 - $76.2000) on Tue. Mar. 24, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.68% (three month average) | RSI | 36 | Latest Price | $74.1800(5.16%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.3% a day on average for past five trading days. | Weekly Trend | LGND declines -15% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(54%) IWC(53%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -2.84% in a week (0% probabilities). VIXM(-31%) VXX(-18%) TLT(-13%) UUP(-5%) IGOV(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.84% (StdDev 5.68%) | Hourly BBV | 0 () | Intraday Trend | 3.7% | | | |
|
1 - 5 Day Possible Target | $49.61(-33.12%) | Resistance Level | $88.82 | 5 Day Moving Average | $74.8(-0.83%) | 10 Day Moving Average | $76.93(-3.57%) | 20 Day Moving Average | $88.82(-16.48%) | To recent high | -31.4% | To recent low | 17.1% | Market Cap | $1.192b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |